GPhA lauds Christie for signing N.J. biosimilar bill

WASHINGTON — This week, New Jersey Gov. Chris Christie had signed a bill into law that allows pharmacists to exchange a Food and Drug Administration-approved biosimilar for a biologic product. This move makes New Jersey the latest of 12 states and Puerto Rico that has adopted similar legislation in 2015. 

 

The Generic Pharmaceutical Association and its Biosimilar Council voiced its support for the move with a statement from president and CEO Chip Davis. 

 

“This year for biosimilars continues to be one of progress and promise,” said Chip Davis. “We are very pleased that state policymakers in New Jersey and across the country are ensuring pharmaceutical competition and promoting patient access to more affordable medicine.”